Arriving in the landscape of obesity therapy, retatrutide represents a distinct approach. Unlike many available medications, retatrutide works as a double agonist, concurrently affecting both GLP peptide-1 (GLP-1) and https://joycejbek464403.vblogetin.com/44648920/the-novel-retatrutide-the-glp-gip-receptor-agonist